Page last updated: 2024-11-02

pindolol and Eczema

pindolol has been researched along with Eczema in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Eczema: A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).

Research Excerpts

ExcerptRelevanceReference
"The binding of (-)-3H-dihydroalprenolol (3H-DHA) and 125I-hydroxybenzylpindolol (125I-HYP) to the beta-adrenergic receptors in homogenized granulocyte preparations from control subjects and patients with atopic eczema was characterized."3.66Characterization of granulocyte beta adrenergic receptors in atopic eczema. ( Busse, WW; DeClerque, JL; Ruoho, AE, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruoho, AE1
DeClerque, JL1
Busse, WW1

Other Studies

1 other study available for pindolol and Eczema

ArticleYear
Characterization of granulocyte beta adrenergic receptors in atopic eczema.
    The Journal of allergy and clinical immunology, 1980, Volume: 66, Issue:1

    Topics: Adult; Binding Sites; Dihydroalprenolol; Eczema; Female; Granulocytes; Humans; Hypersensitivity, Imm

1980